Sensitivity analysis of different HER2 clone numbers for detecting HER2 low and ultra-low expression in invasive breast cancer

被引：0
|
作者：
Liu, Y. [1 ]
Shang, J. [1 ]
He, J. [1 ]
Ding, Y. [1 ]
Li, J. [1 ]
机构：
[1] Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R China
来源：
VIRCHOWS ARCHIV | 2024年 / 485卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
E-PS-02-05
引用
收藏
页码：S197 / S198
页数：2
相关论文
共 50 条
  • [31] Prognostic difference between early breast cancer patients with HER2 low and HER2 zero status
    Cha, Chihwan David
    Kim, Kyung Eun
    Kim, Jungbin
    Um, Eunhae
    Choi, Nayeon
    Lee, Jungsun
    Gwak, Geumhee
    Kim, Jae Il
    Chung, Min Sung
    NPJ BREAST CANCER, 2025, 11 (01)
  • [32] Prognostic factors in nonmetastatic HER2 'low' & HER2 'negative' breast cancer: Single institute experience
    Turkel, A.
    Dogan, M.
    Sertesen, E.
    Karacin, C.
    Irkkan, S. C.
    Ates, O.
    ANNALS OF ONCOLOGY, 2023, 34 : S299 - S300
  • [33] Precision HER2: a comprehensive AI system for accurate and consistent evaluation of HER2 expression in invasive breast Cancer
    Xiong, Zhongtang
    Liu, Kai
    Liu, Shaoyan
    Feng, Jiahao
    Wang, Jin
    Feng, Zewen
    Lai, Boan
    Zhang, Qingxin
    Jiang, Qingping
    Zhang, Wei
    BMC CANCER, 2024, 24 (01)
  • [34] Improving HER2 testing reproducibility in HER2-low breast cancer
    Sajjadi, Elham
    Venetis, Konstantinos
    Ivanova, Mariia
    Fusco, Nicola
    CANCER DRUG RESISTANCE, 2022, 5 (04) : 882 - 888
  • [35] A Single-Center Experience with HER2 Testing and Low Level HER2 Expression in Endometrial Cancer
    Menshikova, Ekaterina
    Deeb, Kristin
    Genega, Elizabeth
    Wang, Qun
    Hanley, Krisztina
    Turashvili, Gulisa
    LABORATORY INVESTIGATION, 2024, 104 (03) : S1210 - S1210
  • [36] Breast Cancer and HER2 Over Expression
    Devgan, Manish
    Mohan, Ankur
    Gangwar, Pallavi
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL AND PHYTOPHARMACOLOGICAL RESEARCH, 2014, 3 (05): : 395 - 398
  • [37] HER2 Expression in Breast Cancer With Nonamplified HER2 and Gains of Chromosome 17 Centromere
    Panvichian, Ravat
    Tantiwetrueangdet, Anchalee
    Wongwaisayawan, Sansanee
    Nampoon, Amporn
    Lertsithichai, Panuwat
    Leelaudomlipi, Surasak
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2012, 20 (04) : 367 - 374
  • [38] Analysis of HER2 expression changes from breast primary to brain metastases including HER2 Low and impact on overall survival
    Pereslete, Alyssa
    Hughes, Melissa
    Patterson, Alyssa
    Files, Janet
    Nguyen, Kyleen
    Buckley, Lauren
    Patel, Ashka
    Moore, Abigail
    Winer, Eric
    Li, Tianyu
    Tolaney, Sara
    Lin, Nancy
    Sammons, Sarah
    CANCER RESEARCH, 2024, 84 (09)
  • [39] HER2 Gene Protein Assay Is Useful to Determine HER2 Status and Evaluate HER2 Heterogeneity in HER2 Equivocal Breast Cancer
    Hou, Yanjun
    Nitta, Hiroaki
    Li, Zaibo
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2017, 147 (01) : 89 - 95
  • [40] Evaluation of HER2 scoring algorithms for identification of HER2-low breast cancer
    Costache, S.
    Nagy, A.
    Billingham, K.
    Haynes, H.
    Chefani, A.
    Thomas, T.
    Wedden, S.
    D'Arrigo, C.
    VIRCHOWS ARCHIV, 2020, 477 : S222 - S223
12345